Lexeo Therapeutics, Inc. · NASDAQ:LXEO
Lexeo Therapeutics, Inc. shareholders
As of Jun 30, 2026, 137 institutions reported holding Lexeo Therapeutics, Inc. Largest: Montanova Capital, LLC, Affinity Asset Advisors, LLC and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Lexeo Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Montanova Capital, LLC | 6.38M | +5.13M | Aug 14, 2026 | |
| Affinity Asset Advisors, LLC | 5.81M | +757K | Aug 13, 2026 | |
| BlackRock | 5.74M | +629K | Aug 7, 2026 | |
| Ra Capital Management, L.P. | 5M | no change | Aug 14, 2026 | |
| Frazier Life Sciences Management, L.P. | 4.82M | +400K | Aug 14, 2026 | |
| State Street | 4.35M | +787K | Aug 7, 2026 | |
| Vestal Point Capital, LP | 4.32M | −155K | Aug 14, 2026 | |
| Vanguard | 4.21M | +184K | Aug 13, 2026 | |
| Paradigm Biocapital Advisors LP | 4.18M | −2.01M | Aug 14, 2026 | |
| Jupiter Topco LLC | 3.95M | first report | Aug 14, 2026 |